TAIKO PHARMACEUTICAL CO., LTD.JP:4574Balance sheet

Market cap
¥14.6B
P/E ratio
25x
2014/032015/032016/032017/032018/032019/032020/032020/122021/122022/122023/122024/12
Cash and cash equivalents -6,1192,9976,8036,5487,2259,9064,9455,7963,1055,4844,532
Marketable securities, current --------302400--
Accounts receivable, net-1,8632,1961,8213,3853,6464,4197,9194,0561,7981,9852,428
Inventories-1,3288886948348791,3465,4092,010696421452
Total current assets-10,4787,43310,27611,76412,57216,58419,82213,7837,5569,1098,761
Property, plant and equipment, net-7,6288,4108,0767,8957,3717,1089,4477,1136,3973,5813,271
Marketable securities, non-current ---213327417351,2311,011533236461
Total non-current assets-8,1218,8758,5138,7099,0288,89011,9368,7517,4894,1114,152
Total assets -18,59916,30718,78920,47321,60025,47431,75822,53515,04613,22012,914
Accounts payable-3502393024245141,0062,929309274375338
Long-term debt, current --------9231,0391,2061,206
Total current liabilities-5,0042,0082,2372,8162,8264,7947,4884,3202,7933,0462,855
Long-term debt, non-current --------3,7602,7201,999792
Total non-current liabilities-1,1221,1601,1671,2371,2881,3051,4895,4074,2083,4332,094
Total liabilities -6,1263,1683,4044,0534,1156,1008,9769,7287,0016,4804,949
Common stock and paid-in capital -6398181,3691,5731,7592,2712,6642,8492,8434,9565,007
Retained earnings-12,47612,99613,85014,66315,57917,53320,50910,1345,2391,6282,526
Stockholders' equity11,40612,47313,14015,38516,42017,48519,37422,78112,8078,0446,7397,964